Donor-Specific Antibody Detection via Bead-Based Immune Complex Capture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting donor specific antibodies (DSAs) in transplant recipients are inadequate, leading to suboptimal long-term graft function and increased risk of graft rejection due to inability to accurately identify and quantify these antibodies, especially in the context of antibody-mediated rejection.
Innovation Solution
A method involving the formation of a mixture of a cellular sample from a donor and a biological sample from a recipient, where recipient immune antibodies bind to donor cell surface antigens, followed by contact with beads coated with antibodies specific to the immune antibody-Ag complex and subsequent detection with a detectably-labeled antibody, allowing for the determination of DSA presence or absence using flow cytometry or Luminex technology.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current DSA detection methods are used, then the detection process is simple, but the measurement precision and reliability are insufficient leading to suboptimal graft function monitoring
Solution Approach 1:
The detection method is divided into distinct sequential steps: (1) incubating recipient serum with donor cells to form immune complexes, (2) adding beads coated with antibodies specific to the immune complex, (3) washing to separate bound from unbound materials, and (4) detecting bound antibodies. This segmentation allows each step to be optimized for precision while maintaining overall manageability.
Solution Approach 2:
Beads coated with antibodies specific to the immune antibody-Ag complex serve as an intermediary element. These beads capture the immune complexes from the recipient serum and provide a solid phase for subsequent detection, enhancing measurement precision while simplifying the detection workflow through standardized bead-based assays.
2Reliability
If current DSA detection methods are used, then the procedure is quick and simple, but the reliability of graft rejection risk assessment is compromised
Solution Approach 1:
The method performs preliminary incubation of recipient serum with donor cells before detection, allowing immune complexes to form in advance. This preliminary action ensures that the actual detection step only needs to measure pre-formed complexes, improving reliability of rejection risk assessment while keeping the overall process manageable through pre-prepared reagents and controls.
Solution Approach 2:
The detection system provides quantitative feedback on DSA levels through measurement of bound antibodies on beads. This feedback mechanism allows for reliable assessment of graft rejection risk by correlating antibody levels with clinical outcomes, enabling more informed clinical decision-making despite increased analytical complexity.
3Reliability
If more sensitive DSA detection is implemented, then graft survival rates improve, but the detection method becomes more complex requiring additional reagents and steps
Solution Approach 1:
The bead-based detection system uses universal beads coated with antibodies that can detect multiple types of immune complexes. This multi-functionality allows a single detection platform to assess various DSA specificities, improving graft survival monitoring without requiring separate specialized assays for each antibody type, thus limiting the increase in overall complexity.
Solution Approach 2:
The method enhances detection sensitivity by changing parameters such as using beads with high antibody binding capacity, optimizing incubation conditions, and employing sensitive detection reagents. These parameter changes improve graft survival monitoring capability while maintaining protocol manageability through standardized optimization rather than fundamentally complex new approaches.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a more sensitive and specific detection of DSAs, reducing the risk of graft rejection by accurately identifying and quantifying donor-specific antibodies, thereby improving graft survival rates and reducing chronic rejection.
Implementation Method 1
combining a cellular sample from a donor with a biological sample from a recipient under conditions sufficient for recipient immune antibodies, if present, to bind to donor cell surface antigen (Ag) to form an immune antibody-Ag complex
Implementation Method 2
contacting the mixture with beads comprising an antibody that specifically binds the immune antibody-Ag complex (e.g., the Ag or immune antibody) on a surface thereof
Implementation Method 3
adding under lysis conditions a detectably-labeled antibody that specifically binds the immune antibody-Ag complex bound to the beads
Data Source
AI summary
Provided are methods for determining the presence or absence of donor specific antibodies in a biological sample. The methods include mixing a cellular sample from a donor with a biological sample from a recipient under conditions sufficient for recipient immune antibodies, if present, to bind to donor cell surface antigen (Ag) to form an immune antibody-Ag complex, contacting the mixture with beads comprising an antibody that specifically binds the immune antibody-Ag complex (e.g., the Ag or immune antibody) on a surface thereof, adding under lysis conditions a detectably-labeled antibody that specifically binds the immune antibody-Ag complex bound to the beads, and detecting the presence or absence of the detectably-labeled antibody bound to the immune antibody-Ag complex to determine the presence or absence of donor specific antibodies in the biological sample from the recipient. Systems and kits for practicing the subject methods are also provided.